Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on TSRX
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
TRIUS THERAPEUTICS (NQ:TSRX)
Delayed:
7.90
+0.30 (3.95%)
Trade Now!
Previous Close
$7.60
52 Week High
$8.50
Open
$7.52
52 Week Low
$4.41
Day High
$7.91
P/E
N/A
Day Low
$7.37
EPS
$-1.57
Volume
923,814
Friends, Peers and Foes
(?)
:
FURX
,
ARQL
,
OPTR
,
PCYC
,
TSR
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 23, 2013 05:53 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: Fischer Seth H.Z.
May 23, 2013 05:53 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: Kjellson Nina S
May 23, 2013 05:51 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: O'Leary Brendan
May 23, 2013 05:50 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: TRUEX PAUL F
May 23, 2013 05:49 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: Schroeder Theodore R
May 23, 2013 05:49 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: ATWOOD BRIAN G
May 23, 2013 05:48 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: EASTHAM KARIN
May 23, 2013 05:47 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: KABAKOFF DAVID S
May 16, 2013 02:42 PM
Form 4 Trius Therapeutics Inc For: May 14 Filed by: MORNEAU MICHAEL
May 16, 2013 02:29 PM
Form 4 Trius Therapeutics Inc For: May 14 Filed by: Finn John
View All Articles
May 8, 2012 04:19 PM
Trius Therapeutics, Inc. (TSRX) Posts Better than Expected Q1 Results
Mar 13, 2012 08:12 AM
Trius Therapeutics (TSRX) Posts Narrower than Expected Q4 Loss of 44c/Share
May 13, 2013 08:03 AM
Trius Therapeutics (TSRX) Tedizolid Phosphate Portfolio Receives NoA from UPTO
May 10, 2013 10:47 AM
Notable Analyst Rating Changes 05/10: (FST) (EIX) (BSX) Upgraded; (MDR) (DNDN) (LTD) Downgraded
May 10, 2013 07:26 AM
Guggenheim Starts Trius Therapeutics (TSRX) at Buy
Mar 25, 2013 09:30 AM
StreetInsider.com Pre-Open Movers 03/25: (APOL) (DG) (DELL) Higher; (OTT) (IDIX) (BBRY) Lower (more...)
Mar 25, 2013 07:15 AM
Trius (TSRX) ESTABLISH 2 Phase 3 Met Primary, Seconadry Endpoints
Jan 18, 2013 09:31 AM
StreetInsider.com Pre-Open Movers 01/18: (PATH) (LIFE) (MS) Higher; (FNSR) (COF) (TSRX) Lower (more...)
Jan 18, 2013 08:02 AM
Trius Therapeutics (TSRX) Prices $6.3M Stock Offering at $4.75/Share
Jan 17, 2013 06:06 PM
Streetinsider.com After-Hours Movers 1/17: (AM) (GERN) Higher; (COF) (TSRX) (INTC) Lower (more...)
Jan 17, 2013 04:25 PM
Trius Therapeutics (TSRX) Announces Common Stock Offering
Jan 7, 2013 08:05 AM
Tedizolid (TSRX) Recieves QIDP Designation, Action Expedites FDA Review
View All Reports
May 13, 2013 08:01 AM
Trius Announces Notice of Allowance of U.S. Patent Application Related to Tedizolid Phosphate Combination With Daptomycin
May 7, 2013 04:00 PM
Trius Therapeutics Reports First Quarter 2013 Financial Results
Apr 29, 2013 08:00 AM
Trius Therapeutics Presents Clinical Data on Experimental Antibiotic Tedizolid at ECCMID Meeting
Apr 23, 2013 08:00 AM
Trius Therapeutics to Present Experimental Antibiotic Study Results at ECCMID Meeting
Apr 3, 2013 04:00 PM
Trius Appoints Seth Fischer to Its Board of Directors
Apr 2, 2013 04:00 PM
Trius to Present at Future Leaders Conference
Mar 25, 2013 07:00 AM
Trius Announces Positive Results From ESTABLISH 2 Study of Tedizolid in Severe Skin Infections
View All Press Releases
May 23, 2013 05:53 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: Fischer Seth H.Z.
May 23, 2013 05:53 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: Kjellson Nina S
May 23, 2013 05:51 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: O'Leary Brendan
May 23, 2013 05:50 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: TRUEX PAUL F
May 23, 2013 05:49 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: Schroeder Theodore R
May 23, 2013 05:49 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: ATWOOD BRIAN G
May 23, 2013 05:48 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: EASTHAM KARIN
May 23, 2013 05:47 PM
Form 4 Trius Therapeutics Inc For: May 21 Filed by: KABAKOFF DAVID S
May 16, 2013 02:42 PM
Form 4 Trius Therapeutics Inc For: May 14 Filed by: MORNEAU MICHAEL
May 16, 2013 02:29 PM
Form 4 Trius Therapeutics Inc For: May 14 Filed by: Finn John
View All Filings
Entities mentioned with
TSRX
Piper Jaffray
|
View Related Stories »
Robert W Baird
|
View Related Stories »
Citi
|
View Related Stories »
Earnings
|
View Related Stories »
Credit Suisse
|
View Related Stories »
JMP Securities
|
View Related Stories »
Standard & Poor's
|
View Related Stories »
Amgen/Micromet
|
View Related Stories »
Bank of America
|
View Related Stories »
Canaccord Adams
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
After-Hours Movers
|
View Related Stories »
SunTrust Robinson Humphrey
|
View Related Stories »
Roth Capital
|
View Related Stories »
Unusual 11 Mid-Day Movers
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
Wells Fargo
|
View Related Stories »
Needham & Company
|
View Related Stories »
Ladenburg Thalmann Financial Services
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Bankruptcy
|
View Related Stories »
BI-LO/Winn-Dixie Stores
|
View Related Stories »
Stifel Nicolaus
|
View Related Stories »
UBS
|
View Related Stories »
Rodman & Renshaw
|
View Related Stories »
Show More...
View All Entities